ALLERGY THERAPT Cash Flow - Annual (OTCMKTS:AGYTF)

Add to My Stocks
$0.34 $0 (0%) AGYTF stock closing price Sep 20, 2018 (Closing)

The financial analysis of AGYTF requires an investor to check the cash flows for ALLERGY THERAPT. Financials statements like the ALLERGY THERAPT income statement and ALLERGY THERAPT balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the ALLERGY THERAPT stock analysis. ALLERGY THERAPT generated $-17.56M cash from operating activities in 2016. ALLERGY THERAPT has a positive cash and cash equivalents change of $3.27M.

View details of ALLERGY THERAPT cash flows for latest & last 10 financial years
show more
Fiscal year is Jul - Jun2016
Net Income Cash Flow
-17.9M
Depreciation Depletion Amortization Cash-Flow2.47M
Net Increase (Decrease) in Assets Liabilities-2.15M
Cash From (used in) Discontinued Operations-
Other Adjustments Net-
Net Cash from (used by) Operating Activities
-17.56M
Increase (Decrease) in Prop Plant And Equipment-1.82M
Acquisition Disposition of Subsidiaires-
Increase (Decrease) in Investments-
Other Cash Inflow (Outflow) from Investment Activities-0.38M
Net Cash from (used by) Investment Activities
-2.21M
Issuance (Purchase) of Equity Shares16.27M
Issuance (Repayment) of Debt Securities2.33M
Increase (Decrease) in Bank & Other Borrowings-
Payment of Dividends & Other Cash Distributions-
Other Cash from (used by) Financing Activities-
Net Cash from (used by) Financing Activities
18.6M
Effect of Exchange Rate Changes on Cash4.45M
Net Change in Cash & Cash Equivalents
3.27M
Cash & Equivalents at Beginning of Year31.45M
Cash & Equivalents at Year End34.73M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The ALLERGY THERAPT stock price history and ALLERGY THERAPT stock comparison chart inevitably reflect its cash flow situation.

  • ALLERGY THERAPT had a Net Change in Cash and Cash Equivalents of $3.27M for the latest year 2016. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the ALLERGY THERAPT stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: ALLERGY THERAPT reported a negative operating cash flow of $-17.56M for 2016 and has seen an increase from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash from investing stood at a negative value of $-2.21M for AGYTF stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $18.6M for ALLERGY THERAPT.

Key Financial Ratios For ALLERGY THERAPT Cash Flow

Annual Cash Flow Statements For ALLERGY THERAPT Peers

AcelRx Pharma cash flow, KALVISTA PHARMA cash flow, Lannett Co cash flow